Last week Pedro Silva, President of the Direction, and Bárbara Gomes, AccelBio’s CEO, were in Tel Aviv to get to know the Israeli innovation ecosystem.
With meetings with Tel Aviv University (Blavatnik Center for Drug Discovery) and Weizmann Institute of Science (Bina and Yeda), this was an excellent opportunity to learn about different perspectives and methodologies in the area of academic innovation and technology transfer.
We look forward to continuing our collaboration in the future.
Sign up with your email address to receive news and updates.
By subscribing to receive news and updates you are automatically agreeing with our Terms & Conditions and Privacy Policy.
CoLAB AccelBio is one of the partners in the "Health from Portugal" Mobilizing Agenda, led by Prologica, and approved under the Portuguese Economic...
In partnership with the Portuguese Society of Stem Cells and Cell Therapy (SPCE-TC), and in an effort to promote and inspire research in the field...
AccelBio, in collaboration with its Associate, Instituto de Medicina Molecular, had the distinct pleasure of hosting Anton Hutter from Venner...